Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study

The purpose of this study was to evaluate the activity, measured in terms of progression-free survival (PFS) and response rates, of 1,3-bis(chloroethyl)-1-nitrosourea (BCNU) plus temozolomide in adult patients with recurrent glioblastoma multiforme. The phase 2 dose and schedule for this trial was B...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Prados, Michael D., Yung, W.K. Alfred, Fine, Howard A., Greenberg, Harry S., Junck, Larry, Chang, Susan M., Nicholas, M. Kelly, Robins, H. Ian, Mehta, Minesh P., Fink, Karen L., Jaeckle, Kurt A., Kuhn, John, Hess, Kenneth R., Schold, S. Clifford
Formato: Artigo
Idioma:Inglês
Publicado em: Duke University Press 2004
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1871975/
https://ncbi.nlm.nih.gov/pubmed/14769138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1215/S1152851703000309
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados